Client Spotlight: AltaThera Pharmaceuticals LLC – Optimizing Care to Improve Patient Outcomes
AltaThera Pharmaceuticals LLC – Optimizing Care to Improve Patient Outcomes AltaThera Pharmaceuticals LLC is a commercial stage hospital-focused pharmaceutical company applying innovative science to address unmet medical needs while reducing healthcare costs. AltaThera is committed to providing therapies that increase efficient treatment of the complex challenges of atrial fibrillation (AFib), a serious and costly health […]
Client Spotlight: Timberland Partners
Timberland Partners is a Minneapolis-based real estate investment and management company focused exclusively on the multifamily apartment sector. In business for over 28 years, Timberland Partners owns and operates a +17,000-unit, $2 billion portfolio across the central and southeastern United States. The company specializes in value-add investments across growing secondary and tertiary markets. The company’s […]
Client Spotlight: PYC Therapeutics
Client Spotlight: PYC Therapeutics PYC Therapeutics is part of the ‘precision medicine’ revolution targeting rare genetic diseases. The company combines world-class expertise in RNA drug design with propriety intracellular delivery technology to develop highly precise and safe medicines. Company highlights include: Proven RNA expertise – PYC’s Chief of R&D has co-invented two FDA approved drugs […]
Colton Alexander LLC – Not another Investment Bank!
Colton Alexander LLC – Not another Investment Bank! Colton Alexander LLC, an affiliate of Weild & Co., broker-dealer, provides strategic advisory services to public and private sector issuers through private placements of debt and equity, mergers and acquisitions, private markets research and advisory. Weild & Co. founder David Weild IV has had a distinguished career […]
Profile: Choice Housing Investments
Profile: Choice Housing Investments Choice Housing Investments (CHI) is a leading multi-family residential real estate investment firm that identifies, underwrites and invests in various types of real estate investments ranging from stabilized assets to value-add opportunities that require market repositioning. As a synergistic real estate finance company, CHI leverages its relationship with affiliate Vesta Corporation, […]
Member Spotlight: eStatePlan
Member Spotlight: eStatePlan Every family office needs a strong estate plan that includes a Revocable Living Trust, Last Will and Testament, Power of Attorney Forms and Healthcare Directives. EPTM meets this need with an online estate planning platform that allows families, with their assigned network attorney, to create a living trust estate plan that is electronically […]
Client Spotlight – Akamara Therapeutics, Inc.
Client Spotlight – Akamara Therapeutics, Inc. Akamara Therapeutics is a private immunotherapy company seeking to change the way people live by developing innovative B cell therapeutics. Akamara is well positioned to capitalize on important emerging science supporting B cell activation as a therapeutic approach in human cancer. Despite positive impact on survival by approved immuno-oncology […]
Member Profile – SCENES™ Media
Member Profile – SCENES™ Media The music industry is one of the hardest hit businesses during the coronavirus pandemic. Almost all artists these days, even those with very high profiles, rely on touring for their income. With club dates and tour dates canceled, the Internet audience for online music and culture continues to explode. Indeed, every crisis […]
Member Spotlight – Keena Wealth
Member Spotlight Keena Wealth “AT OUR FIRM, WE HAVE THE CLIENT—AND ONLY THE CLIENT—IN MIND” Tony Keena, Founder of Keena Wealth in Winter Park, Florida, started his firm for a deeply personal reason – he repeatedly saw many friends and family struggling to find the help they needed to map out their financial future. “We […]
Interview with Craig W. Philips, President of Kineta, Inc.
Investing in Biotech Companies: Interview with Craig W. Philips, President of Kineta, Inc. Over the previous few months, we have interviewed a number of the scientific staff at Kineta. They have shared information about their novel new drug programs in immuno-oncology, their partnership with Pfizer for one of Kineta’s novel cancer drugs, and their partnership […]